Approvals/TGA/VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe

Approved

STANDARD

VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: a2d36a8ae4ea8489
Company: Merck Sharp & Dohme (Australia) Pty Ltd
Type: Standard

Approval Details

Approval Id: a2d36a8ae4ea8489
Product Name: VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe
Artg Id: 350791
Artg Name: VAXNEUVANCE Pneumococcal 15-valent Conjugate Vaccine [CRM197 Protein], adsorbed 0.5 mL Suspension for intramuscular injection, Pre-filled syringe
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2022-01-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c3771030ebaeaa1d9814f7c8be2c9fc8.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/a9af53e07d311d60bd38f9028bbe602d.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

a2d36a8ae4ea8489

Type

Standard

Back to TGA Approvals